Drug Trial Radar · NCT03847896
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
Last checked: Nov 19, 2026Latest source record: Apr 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,001
Actual
Start
Mar 20, 2019
Primary completion
Jul 20, 2021
Study completion Jul 20, 2021
Sponsor
- Lead sponsor
- Bond Avillion 2 Development LPIndustry
- Sponsor type
- Industry
- First posted
- Feb 20, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare 2 dose levels of budesonide/albuterol BDA MDI (PT027) to its components budesonide BD MDI (PT008) and albuterol AS MDI (PT007) on improvement in lung function and asthma symptoms after 12 weeks of treatment in adult, adolescent, and child subjects with symptomatic asthma currently being treated with a short/rapid-acting β2-adrenoreceptor agonist (SABA) as needed alone or with low-dose inhaled corticosteroid (ICS) maintenance therapy plus SABA as needed.
Conditions
- Asthma
Interventions
Budesonide/albuterol sulfate metered dose inhaler / BDA MDI 160/180 μg (high dose)Combination product
Budesonide/albuterol sulfate pressurized metered dose inhaler (BDA MDI) 160/180 micrograms (μg), given as 2 inhalations of BDA MDI 80/90 μg, four times a day (QID)
Budesonide/albuterol sulfate metered dose inhaler / BDA MDI 80/180 μg (low dose)Combination product
Budesonide/albuterol sulfate pressurized metered dose inhaler (BDA MDI) 80/180 micrograms (μg), given as 2 inhalations of BDA MDI 40/90 μg, four times a day (QID)
Budesonide metered dose inhaler / BD MDI 160 µgDrug
Budesonide pressurized metered dose inhaler (BD MDI) 160 micrograms (μg), given as 2 inhalations of BD MDI 80 μg, four times a day (QID)
Albuterol sulfate metered dose inhaler / AS MDI 180 μgDrug
Albuterol sulfate pressurized metered dose inhaler (AS MDI) 180 micrograms (μg), given as 2 inhalations of AS MDI 90 μg, four times a day (QID)
Placebo metered-dose inhaler / Placebo MDIOther
Placebo pressurized metered dose inhaler (Placebo MDI), given as 2 inhalations of Placebo MDI, four times a day (QID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Forced Expiratory Volume in 1 Second (FEV1) Area Under the Concentration Curve From 0 to 6 Hours (AUC0-6 Hours) Over 12 WeeksTime frame: Baseline and 12 weeks
- Change From Baseline in Trough FEV1Time frame: Baseline and 12 weeks
Locations
129 sites in 7 countries. Site status is shown where the registry gives one.
Research Site
Mobile, Alabama
Research Site
Bakersfield, California
Research Site
Costa Mesa, California
Research Site
Encinitas, California
Research Site
Huntington Beach, California
Research Site
Lancaster, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Research Site
Roseville, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Jose, California
Research Site
Waterbury, Connecticut
Research Site
Aventura, Florida
Research Site
Clearwater, Florida
Research Site
Gainesville, Florida
Research Site
Greenacres City, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
Oviedo, Florida
Research Site
Palmetto Bay, Florida
Research Site
Pembroke Pines, Florida
Research Site
Pembroke Pines, Florida
Research Site
Meridian, Idaho
Research Site
Chicago, Illinois
Research Site
Chicago, Illinois
Research Site
White Marsh, Maryland
Research Site
Boston, Massachusetts
Research Site
North Dartmouth, Massachusetts
Research Site
Farmington Hills, Michigan
Research Site
Flint, Michigan
Research Site
Rochester Hills, Michigan
Research Site
Woodbury, Minnesota
Research Site
Columbia, Missouri
Research Site
Rolla, Missouri
Research Site
St Louis, Missouri
Showing 40 of 129 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.